Pernix Therapeutics, Inc. to Present at the Canaccord Genuity 32nd Annual Global Growth Conference

Published: Aug 09, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the Canaccord Genuity 32nd Annual Global Growth Conference on Thursday, August 16, 2012 at 8:30 a.m. EDT. The conference will be held at the InterContinental Boston in Boston, MA.

Back to news